We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+13.27%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$3.34B
AUM Growth
+$200M
Cap. Flow
-$154M
Cap. Flow %
-4.62%
Top 10 Hldgs %
11.94%
Holding
449
New
28
Increased
142
Reduced
217
Closed
32

Top Sells

Rank Stock Value
1
DIOD icon
Diodes
DIOD
+$19.2M
2
SAIA icon
Saia
SAIA
+$18.2M
3
PWR icon
Quanta Services
PWR
+$9.81M
4
AAPL icon
Apple
AAPL
+$9.1M
5
EXC icon
Exelon
EXC
+$8.79M

Sector Composition

Rank Sector Weight
1 Financials 18.69%
2 Technology 16.55%
3 Industrials 13.91%
4 Consumer Discretionary 13.71%
5 Healthcare 10.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMGN icon
376
Amgen
AMGN
$222B
$701K 0.02%
2,816
-195
-6% -$46.5K
BBIO icon
377
BridgeBio Pharma
BBIO
$16.5B
$699K 0.02%
+11,345
New +$742K
KLAC icon
378
KLA
KLAC
$259B
$694K 0.02%
21,000
IGSB icon
379
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.3B
$673K 0.02%
12,310
+2,775
+29% +$152K
SHY icon
380
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$660K 0.02%
7,650
-139
-2% -$12K
CURI icon
381
CuriosityStream
CURI
$161M
$647K 0.02%
+47,781
New +$827K
IVV icon
382
iShares Core S&P 500 ETF
IVV
$904B
$643K 0.02%
1,616
CCXI
383
DELISTED
ChemoCentryx, Inc.
CCXI
$637K 0.02%
12,430
-667
-5% -$40.1K
CNTY icon
384
Century Casinos
CNTY
$34M
$611K 0.02%
+59,503
New +$496K
TER icon
385
Teradyne
TER
$59.3B
$595K 0.02%
4,892
LOPE icon
386
Grand Canyon Education
LOPE
$3.98B
$574K 0.02%
5,359
-371
-6% -$36.9K
HARP
387
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$568K 0.02%
2,716
-146
-5% -$29.3K
NMTR
388
DELISTED
9 Meters Biopharma
NMTR
$552K 0.02%
+23,580
New +$725K
BHVN
389
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$535K 0.02%
7,833
-230
-3% -$18.6K
ARGX icon
390
argenx
ARGX
$54.1B
$534K 0.02%
+1,939
New +$613K
AFMD
391
DELISTED
Affimed
AFMD
$533K 0.02%
6,738
-362
-5% -$23.5K
TREX icon
392
Trex
TREX
$5.01B
$478K 0.01%
5,222
PH icon
393
Parker-Hannifin
PH
$135B
$472K 0.01%
1,495
DAR icon
394
Darling Ingredients
DAR
$9.44B
$467K 0.01%
+6,343
New +$436K
AGG icon
395
iShares Core US Aggregate Bond ETF
AGG
$138B
$463K 0.01%
4,070
-581
-12% -$67.3K
FATE icon
396
Fate Therapeutics
FATE
$326M
$463K 0.01%
5,610
-300
-5% -$28.7K
SRPT icon
397
Sarepta Therapeutics
SRPT
$1.77B
$444K 0.01%
5,964
-413
-6% -$38.1K
TPTX
398
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$442K 0.01%
4,673
-250
-5% -$29.7K
DXCM icon
399
DexCom
DXCM
$32B
$434K 0.01%
4,832
ANSS
400
DELISTED
Ansys
ANSS
$419K 0.01%
1,234

Similar funds

Chartwell Investment Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Chartwell Investment Partners held 449 positions worth $3.34B, up 6.4% from $3.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Chartwell Investment Partners withdrew a net $154M in Q1 2021, closing 32 positions and reducing 217 holdings. Its most notable exit was Helen of Troy, an estimated $4.43M position sold in full.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

Against the trend, Chartwell Investment Partners opened a new position in Integer Holdings worth $20.5M.

  • Chartwell Investment Partners's largest Q1 2021 buy was Integer Holdings: 222,184 shares worth $20.5M.
  • Chartwell Investment Partners added most to AAR Corp in Q1 2021, an estimated $6.9M increase.
  • Chartwell Investment Partners's biggest Q1 2021 reduction was Diodes, cutting an estimated $19.2M.
  • Chartwell Investment Partners fully exited Helen of Troy in Q1 2021, selling an estimated $4.43M.
  • Chartwell Investment Partners's ten largest holdings make up 12% of its $3.34B portfolio in Q1 2021.
  • Chartwell Investment Partners opened 28 new positions and closed 32 in Q1 2021.
  • Chartwell Investment Partners's portfolio value rose 6.4% quarter-over-quarter to $3.34B.

Based on Chartwell Investment Partners's 13F filing for Q1 2021, filed 3 May 2021.